← back to search

Ruth L. Coleman

John Radcliffe Hospital ·
Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research, and Cardiovascular Function and Risk Factors.
h-index
28
citations
3,783
works
131
NIH funding
primary concept
Medicine
email

Recent publications

Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)
The Lancet Diabetes & Endocrinology 2024cited by 52position: middledoi
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease
JAMA 2023cited by 44position: middledoi
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension
Annals of Internal Medicine 2020cited by 86position: middledoi
Long‐term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)
Diabetes Obesity and Metabolism 2019cited by 43position: middledoi
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
The Lancet Diabetes & Endocrinology 2017cited by 526position: middledoi
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
The Lancet Diabetes & Endocrinology 2017cited by 319position: middledoi
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5
JAMA Internal Medicine 2017cited by 206position: middledoi
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
Nature Genetics 2016cited by 227position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rury R. Holman · Indiana University Health6 papers (2017–2024)Ruth Peters · Imperial College London3 papers (2017–2023)Nigel Beckett · St. Thomas Hospital3 papers (2017–2023)Jan A. Staessen · State Key Laboratory of Medical Genomics3 papers (2017–2023)Greg Grandits · University of Minnesota2 papers (2020–2023)William C. Cushman · University of Tennessee Health Science Center2 papers (2020–2023)Jennifer Cluett · Harvard University2 papers (2020–2023)Anthony Ishak · Harvard University2 papers (2020–2023)Addison A. Taylor · Michael E. DeBakey VA Medical Center2 papers (2020–2023)Carol Mita · Harvard University2 papers (2020–2023)Lewis A. Lipsitz · Harvard University2 papers (2020–2023)Stephen P. Juraschek · Harvard University2 papers (2020–2023)Kenneth J. Mukamal · Harvard University2 papers (2020–2023)Barry R. Davis · The University of Texas Health Science Center at Houston2 papers (2020–2023)Lawrence J. Appel · Johns Hopkins University Applied Physics Laboratory2 papers (2020–2023)Jiun‐Ruey Hu · Temple University Hospital2 papers (2020–2023)Jackson T. Wright · MetroHealth2 papers (2020–2023)Edgar R. Miller · Anna Needs Neuroblastoma Answers2 papers (2020–2023)Lutgarde Thijs · KU Leuven2 papers (2020–2023)Ernesto Maddaloni · University of Oxford1 papers (2019–2019)